<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Artificial intelligence</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>How to grow a startup in the AI era: MedTech Spotlight Korea 2026 </title>
      <description>
        <![CDATA[AI and advanced biotechnology are reshaping South Korea’s med-tech sector, but great technology alone is not enough to build a successful medical device company, speakers said at MedTech Innovator’s Medtech Spotlight: New Impact Korea 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729896</guid>
      <pubDate>Tue, 24 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729896-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/AI-startup-art-concept.webp?t=1774299523" type="image/jpeg" medium="image" fileSize="387241">
        <media:title type="plain">AI startup art concept</media:title>
      </media:content>
    </item>
    <item>
      <title>How to grow a startup in the AI era: MedTech Spotlight Korea 2026 </title>
      <description>
        <![CDATA[AI and advanced biotechnology are reshaping South Korea’s med-tech sector, but great technology alone is not enough to build a successful medical device company, speakers said at MedTech Innovator’s Medtech Spotlight: New Impact Korea 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729811</guid>
      <pubDate>Mon, 23 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729811-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/AI-startup-art-concept.webp?t=1774299523" type="image/jpeg" medium="image" fileSize="387241">
        <media:title type="plain">AI startup art concept</media:title>
      </media:content>
    </item>
    <item>
      <title>Radnet acquires Gleamer for up to €230M</title>
      <description>
        <![CDATA[Radnet Inc. acquired Gleamer SAS for up to €230 million (US$267 million) as it continues to expand its position across imaging and acute diagnostic care, while accelerating its move toward AI-powered automated diagnostics. Gleamer will be integrated into Radnet’s subsidiary, Deephealth Inc., strengthening its imaging portfolio, and positioning the company as the world’s largest provider of radiology clinical AI solutions.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729287</guid>
      <pubDate>Tue, 03 Mar 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/729287-radnet-acquires-gleamer-for-up-to-230m</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Digital-handshake.webp?t=1683126686" type="image/jpeg" medium="image" fileSize="453851">
        <media:title type="plain">Digital handshake </media:title>
      </media:content>
    </item>
    <item>
      <title>AI transforming med tech in 2026; clinical need drives investments</title>
      <description>
        <![CDATA[Med-tech companies with an AI component in their solutions will certainly find investors willing to back them. AI after all, is being used to develop more effective, smarter technologies. However, investors will only deploy capital into innovations that address genuine clinical needs. The aging population is driving interest in devices targeting cardiovascular and musculoskeletal disorders, and other solutions geared toward neurological conditions, women’s health and diagnostics are also attracting investor attention.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729072</guid>
      <pubDate>Wed, 18 Feb 2026 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/729072-ai-transforming-med-tech-in-2026-clinical-need-drives-investments</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/AI/AI-medical-illustration.webp?t=1686858173" type="image/jpeg" medium="image" fileSize="216630">
        <media:title type="plain">AI medical illustration </media:title>
      </media:content>
    </item>
    <item>
      <title>Bayosthiti AI to build India-specific RNA sequencing ecosystem</title>
      <description>
        <![CDATA[Bayosthiti AI Pvt Ltd. aims to make RNA sequencing and AI-based preventive health care affordable and accessible for the Indian market, leveraging intellectual property from its parent company, Biostate AI Inc.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727213</guid>
      <pubDate>Tue, 23 Dec 2025 00:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727213-bayosthiti-ai-to-build-india-specific-rna-sequencing-ecosystem</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/thumb/India-digital-map.webp?t=1632951244" type="image/png" medium="image" fileSize="470231">
        <media:title type="plain">India map on technology concept background</media:title>
      </media:content>
    </item>
    <item>
      <title>White House steps in on preemption of state AI law </title>
      <description>
        <![CDATA[The Trump administration has made known that it intends to foster rapid adoption of AI, starting with a repeal of an executive order (EO) issued by the Biden administration. Now, the White House has issued an EO that would override state AI law, a move that addresses a task that Congress to date has failed to complete.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727104</guid>
      <pubDate>Fri, 19 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727104-white-house-steps-in-on-preemption-of-state-ai-law</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/AI/AI_landscape.webp?t=1588275844" type="image/png" medium="image" fileSize="499179">
        <media:title type="plain">AI microchip illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Acryl raises $28M IPO, aiming to bridge medical divide with AI</title>
      <description>
        <![CDATA[Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day, up 243.5% from its offering price, before closing 30% down on Dec. 17 at ₩47,500. Seoul, South Korea-based Acryl sold 2.16 million shares priced at ₩19,500 each. Notably, Acryl won South Korea Ministry of Food and Drug Safety approval of Acryl-D01 software in December 2024, making it the country’s first AI-based digital therapeutic solution for depression screening and diagnosis. The generative AI-based medical software is cleared to analyze patient interviews and medical records and provide a probability score for clinical depression.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727084</guid>
      <pubDate>Wed, 17 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727084-acryl-raises-28m-ipo-aiming-to-bridge-medical-divide-with-ai</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/IPO-stock-market-ticker.webp?t=1596572091" type="image/png" medium="image" fileSize="341793">
        <media:title type="plain">IPO stock market ticker</media:title>
      </media:content>
    </item>
    <item>
      <title>Sparrow feathers nest with C$10M for Stethophone expansion</title>
      <description>
        <![CDATA[Sparrow Acoustics Inc., dba Sparrow Bioacoustics Inc., closed a C$10 million (US$7.15 million) financing round to support continued adoption of its U.S. FDA-cleared Stethophone platform, which allows bioacoustics detection of structural and rhythmic heart anomalies directly through a smartphone. Sparrow is a Software as a Medical Device and the first medically cleared product that uses smartphones to capture and decipher cardiac sounds.]]>
      </description>
      <guid>http://www.bioworld.com/articles/725463</guid>
      <pubDate>Thu, 30 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/725463-sparrow-feathers-nest-with-c10m-for-stethophone-expansion</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2023/6-7--Sparrow-Bioacoustics-smartphone-stethoscope.webp?t=1686171742" type="image/jpeg" medium="image" fileSize="97997">
        <media:title type="plain">Smartphone displaying Stethophone app</media:title>
        <media:description type="plain">Stethophone is a software-based technology that allows doctors and nurses to check a patient’s heart and lung sounds using a smartphone. Credit: Sparrow Bioacoustics</media:description>
      </media:content>
    </item>
    <item>
      <title>Kneu secures $5.6M for neurological disorders platform</title>
      <description>
        <![CDATA[Who knew? In addition to adopting a new name, Kneu Health Ltd. recently raised $5.6 million in a seed funding round for its smart-phone-based platform which helps to monitor neurological disorders  to enable timely intervention. The funds secured will be used to expand commercial operations in the U.S., scale deployments for Parkinson's disease and advance the monitoring capabilities of the platform for dementia.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724909</guid>
      <pubDate>Mon, 13 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724909-kneu-secures-56m-for-neurological-disorders-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-and-Euro-symbol-in-cogwheels.webp?t=1649710820" type="image/png" medium="image" fileSize="240035">
        <media:title type="plain">Dollar sign and Euro symbol in cogwheels</media:title>
      </media:content>
    </item>
    <item>
      <title>Roche secures CE mark for kidney disease algorithm</title>
      <description>
        <![CDATA[Roche Holdings AG received CE-mark for the Kidney Klinrisk algorithm, an AI-based tool developed in collaboration with Klinrisk Inc. to stratify risk and assess the progressive decline in kidney function. The software will help clinicians to make more informed decisions when accessing adults with chronic kidney disease as well as individuals with diabetes or hypertension who are at elevated risk of kidney function decline.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724812</guid>
      <pubDate>Wed, 08 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724812-roche-secures-ce-mark-for-kidney-disease-algorithm</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cancer/Kidney-cancer-illustration.webp?t=1756411372" type="image/jpeg" medium="image" fileSize="565755">
        <media:title type="plain">Illustration of kidney cancer showing tumor inside the kidney</media:title>
      </media:content>
    </item>
    <item>
      <title>Lucem, Revvity partner with Sanofi for early T1D detection</title>
      <description>
        <![CDATA[With a new drug available to slow the progression of type 1 diabetes, Sanofi SA is partnering with two med-tech companies to increase screening for early-stage type 1 diabetes and identify eligible patients.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724487</guid>
      <pubDate>Thu, 02 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724487-lucem-revvity-partner-with-sanofi-for-early-t1d-detection</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Collaboration-illustration.webp?t=1600375790" type="image/png" medium="image" fileSize="669559">
        <media:title type="plain">Deal illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Ultromics' Echogo improves cardiac amyloidosis diagnosis</title>
      <description>
        <![CDATA[A month after raising $55 million to advance its AI-enhanced ultrasound diagnostics for cardiovascular disease, Ultromics Ltd. presented strong results for its U.S. FDA-cleared AI analysis of echocardiograms at the American Society of Echocardiography's 2025 Scientific Sessions in Nashville, Tenn. Ultromics' Echogo Amyloidosis was able to detect cardiac amyloidosis earlier and more accurately than traditional methods, missing fewer cases without increasing unnecessary testing.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724253</guid>
      <pubDate>Fri, 26 Sep 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724253-ultromics-echogo-improves-cardiac-amyloidosis-diagnosis</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Ultromics-22nov24.webp?t=1732312800" type="image/jpeg" medium="image" fileSize="383952">
        <media:title type="plain">Ultromics</media:title>
      </media:content>
    </item>
    <item>
      <title>Eko’s AI-stethoscope more than doubles heart disease detection</title>
      <description>
        <![CDATA[In a real-world study, Eko Health Inc.’s AI-enabled digital stethoscope dramatically increased detection rates for atrial fibrillation, heart failure and valvular heart disease in primary care settings. Researchers from Imperial College London presented results from the study at the European Society of Cardiology in Madrid. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/723737</guid>
      <pubDate>Thu, 11 Sep 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723737-ekos-ai-stethoscope-more-than-doubles-heart-disease-detection</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/eko-health-stethescope-11sept25.webp?t=1757625826" type="image/jpeg" medium="image" fileSize="165628">
        <media:title type="plain">Eko Health AI stethescope</media:title>
        <media:description type="plain">Eko Health Inc. Duo stethoscope. Credit: Courtesy Eko Health</media:description>
      </media:content>
    </item>
    <item>
      <title>Storx sensors monitor fetal health during labor and delivery</title>
      <description>
        <![CDATA[Researchers from the University of California, Davis (UC-Davis) continue to assemble intellectual property in support of their development of methods and techniques which improve the accuracy of wearable sensor technologies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723457</guid>
      <pubDate>Fri, 29 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723457-storx-sensors-monitor-fetal-health-during-labor-and-delivery</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/storx-sensors-29aug25.webp?t=1756498849" type="image/jpeg" medium="image" fileSize="242434">
        <media:title type="plain">Storx Sensors</media:title>
        <media:description type="plain">WO2025171056-A1, “Deep harmonic finesse: signal separation in wearable systems with limited data.”Assignee: The Regents of The University of California}Inventors: Ghiasi, Soheil; Saffarpour, MahyaIPC codes: G06F 18/2134; A61B 5/00; G06N 3/02Publication date: Aug. 14, 2025Earliest priority details: US2024550021, Feb. 24, 2024</media:description>
      </media:content>
    </item>
    <item>
      <title>Signos adds AI to CGM to drive weight loss</title>
      <description>
        <![CDATA[Signos Inc. landed U.S. FDA clearance for its over-the-counter glucose monitoring system, which combines Dexcom Inc.'s non-prescription Stelo continuous glucose monitor with an AI-powered platform focused on weight management and metabolism. The sensor transmits glucose readings to a smartphone app that interprets the data, provides guidance for healthy habits and educates the user. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/723195</guid>
      <pubDate>Thu, 21 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723195-signos-adds-ai-to-cgm-to-drive-weight-loss</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/stelo-21aug25.webp?t=1755813087" type="image/jpeg" medium="image" fileSize="5328">
        <media:title type="plain">Signots Stelo</media:title>
        <media:description type="plain">Signos Stelo CGM. Credit: Courtesy Signos Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Research details new AI-enhanced 3D ultrasound imaging method</title>
      <description>
        <![CDATA[A research team from Pusan National University has developed a novel deep learning model coined Moglo-Net, designed to enable three-dimensional reconstruction of images from hand-held ultrasound procedures.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722819</guid>
      <pubDate>Mon, 11 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722819-research-details-new-ai-enhanced-3d-ultrasound-imaging-method</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/PNU-AI-ultrasound-11aug25.webp?t=1754949023" type="image/jpeg" medium="image" fileSize="263692">
        <media:title type="plain">PNU AI ultrasound</media:title>
        <media:description type="plain">Moglo-Net tracks the motion of the ultrasound transducer using tissue speckle data without the need for external sensors, creating a clear 3D ultrasound volume for accurate visualization of bodily structures, enabling more efficient and safe medical treatments. Credit: PNU</media:description>
      </media:content>
    </item>
    <item>
      <title>Ultromics raises $55M for AI platform to tackle heart failure</title>
      <description>
        <![CDATA[Ultromics Ltd. raised $55 million in a series C financing round to expand its commercial footprint across the U.S. and invest in the development of new AI modules for earlier, more accurate detection of cardiovascular disease, Ross Upton, CEO and founder of Ultromics told <em>BioWorld</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722561</guid>
      <pubDate>Thu, 31 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722561-ultromics-raises-55m-for-ai-platform-to-tackle-heart-failure</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Dollar-sign-between-hands.webp?t=1740610521" type="image/jpeg" medium="image" fileSize="123345">
        <media:title type="plain">Dollar sign between hands</media:title>
      </media:content>
    </item>
    <item>
      <title>AI-based video biomarker developed for aortic stenosis</title>
      <description>
        <![CDATA[Researchers from the Yale University filed for protection of a multi-modal approach to predict the progression risk of a heart condition using artificial intelligence algorithms applied to cardiovascular videos.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722549</guid>
      <pubDate>Wed, 30 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722549-ai-based-video-biomarker-developed-for-aortic-stenosis</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/aortic-stenosis-video-30july25.webp?t=1753914120" type="image/jpeg" medium="image" fileSize="217684">
        <media:title type="plain">Aortic stenosis video</media:title>
        <media:description type="plain">WO2025151635-A1, “A multi-modal video-based progression score for aortic stenosis using artificial intelligence.”Assignee: Yale UniversityInventors: Khera, Rohan; Oikonomou, EvangelosIPC codes: G16H 30/40; G16H 30/20; A61B 8/08; G06T 7/00Publication date: July 27, 2025Earliest priority details: US2024619241, Jan. 9, 2024</media:description>
      </media:content>
    </item>
    <item>
      <title>Trump administration’s AI action draws props from med tech</title>
      <description>
        <![CDATA[The Trump administration released an action plan for AI, which includes an exports program for full-stack AI in areas such as health care. The announcement drew the support of the Advanced Medical Technology Association, which described the initiative as an accelerant for the use of AI in health care and a boon to patient outcomes.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722103</guid>
      <pubDate>Thu, 24 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722103-trump-administrations-ai-action-draws-props-from-med-tech</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-white-house-president.webp?t=1588286767" type="image/png" medium="image" fileSize="1311489">
        <media:title type="plain">U.S. flag and White House podium</media:title>
      </media:content>
    </item>
    <item>
      <title>Carlsmed aims for $100M+ IPO</title>
      <description>
        <![CDATA[Carlsmed Inc. launched its IPO at a price of $14 to $16 per share for 6.7 million shares, which would raise just over $100.5 million at the midpoint. The spinal surgery technology company could well pull in more money, if recent history provides guidance. Most med-tech IPOs this year have settled at the upper end of their price range, with Caris Life Sciences Inc. notably raising its price twice before going public at $21, a dollar more than the top of its initial range.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721954</guid>
      <pubDate>Tue, 15 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721954-carlsmed-aims-for-100m-ipo</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Going-public-ticker.webp?t=1601061733" type="image/png" medium="image" fileSize="617241">
        <media:title type="plain">Going public ticker</media:title>
      </media:content>
    </item>
    <item>
      <title>Lunit, Microsoft to codevelop cloud-based clinical AI solutions</title>
      <description>
        <![CDATA[Lunit Inc. reported a new collaboration with Microsoft Corp. July 2 to jointly develop medical AI programs accessible on Microsoft’s Azure cloud platform.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721647</guid>
      <pubDate>Thu, 03 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721647-lunit-microsoft-to-codevelop-cloud-based-clinical-ai-solutions</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Lunit-10apr25.webp?t=1751573138" type="image/jpeg" medium="image" fileSize="492132">
        <media:title type="plain">Lunit</media:title>
      </media:content>
    </item>
    <item>
      <title>UK’s MHRA first regulatory to join Health AI’s global regulator network</title>
      <description>
        <![CDATA[The U.K. Medicines and Healthcare Products Regulatory Agency reported June 24 it joined a global regulatory network for AI that is part of the Health AI regulatory initiative &ndash; a program that will invite another nine regulatory agencies to take part in the initiative in the months ahead.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721138</guid>
      <pubDate>Mon, 30 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721138-uks-mhra-first-regulatory-to-join-health-ais-global-regulator-network</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-structure/Aging-digital-hourglass-futuristic.webp?t=1724944821" type="image/jpeg" medium="image" fileSize="320796">
        <media:title type="plain">Hourglass on glowing circuit board, symbolizing time and technology</media:title>
      </media:content>
    </item>
    <item>
      <title>Two new options presented at ADA for early diagnosis of T1D</title>
      <description>
        <![CDATA[Classically, the diagnosis of type 1 diabetes comes after a patient presents with unexplained weight loss, extreme thirst and frequent urination and a lab test reveals off-the-charts blood glucose levels. At the 85th Scientific Sessions of the American Diabetes Association in Chicago, researchers highlighted two options – a blood test and a machine learning model – for diagnosing the disease much earlier in its progression, when damage to the pancreas' beta cells could be slowed. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/721219</guid>
      <pubDate>Tue, 24 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721219-two-new-options-presented-at-ada-for-early-diagnosis-of-t1d</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Diabetes/Diabetes-illustration.webp?t=1724186440" type="image/png" medium="image" fileSize="300125">
        <media:title type="plain">Blood glucose chart and monitor, stethoscope, injector pen</media:title>
      </media:content>
    </item>
    <item>
      <title>Deepecho secures FDA clearance for fetal imaging platform</title>
      <description>
        <![CDATA[Deepecho Inc. received the U.S. FDA’s nod for its AI-based platform that assesses fetal biometry and amniotic fluid volume  to improve the efficiency and precision of fetal ultrasound diagnostics.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721206</guid>
      <pubDate>Mon, 23 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721206-deepecho-secures-fda-clearance-for-fetal-imaging-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-library/Digital-health-DNA-gene-therapy-research.webp?t=1686951391" type="image/jpeg" medium="image" fileSize="229766">
        <media:title type="plain">Art concept for gene therapy research</media:title>
      </media:content>
    </item>
    <item>
      <title>Deski raises $6M for Heartfocus cardiac imaging software</title>
      <description>
        <![CDATA[Deski SAS raised $6 million in a seed round to support the launch of its cardiac imaging software, Heartfocus, in the U.S. The AI-driven heart exam tool helps health care professionals perform echocardiograms from any ultrasound probe to enable the early detection of heart disease. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/721151</guid>
      <pubDate>Fri, 20 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721151-deski-raises-6m-for-heartfocus-cardiac-imaging-software</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Deski-HeartFocus-20jun25.webp?t=1750451570" type="image/jpeg" medium="image" fileSize="201599">
        <media:title type="plain">Deski Heart Focus</media:title>
      </media:content>
    </item>
    <item>
      <title>Device for monitoring wounds without removing dressings</title>
      <description>
        <![CDATA[Researchers from the University at Buffalo, the State University of New York (SUNY), filed for protection of their development of a new imaging technology that uses radar and AI to see through dressings to monitor wounds and other skin conditions.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721129</guid>
      <pubDate>Wed, 18 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721129-device-for-monitoring-wounds-without-removing-dressings</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/wound-monitoring-18jun25.webp?t=1750279614" type="image/jpeg" medium="image" fileSize="307849">
        <media:title type="plain">Wound Monitoring</media:title>
        <media:description type="plain">WO2025117987-A1, “System and method for non-contact epidermal sensing.”Assignee: The Research Foundation for The State University of New YorkInventors: Xu, Wenyao; Xia, Jun; Zhang, XiaoyuIPC codes: A61B 5/00; G06T 7/00; G06T 7/62; A61B 5/0507Publication date: June 5, 2025Earliest priority details: US2023604890, Nov. 30, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>GC Genome plans $30M IPO to diversify genomic products, suppliers</title>
      <description>
        <![CDATA[GC Genome Corp. priced a Kosdaq offering of 4 million shares at ₩10,500 per share May 27, entailing a gross ₩42 billion (US$30.5 million) raise in early June. The Yongin, South Korea-based genomics subsidiary of GC Biopharma Corp. fixed its shares price to the top of its ₩9,000 to ₩15,000 price band May 27 after conducting demand forecasting on domestic and international institutional investors from May 19 to May 23.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720488</guid>
      <pubDate>Tue, 27 May 2025 16:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720488-gc-genome-plans-30m-ipo-to-diversify-genomic-products-suppliers</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Research-and-science/DNA-NGS-genome-sequencing.webp?t=1588871366" type="image/png" medium="image" fileSize="527937">
        <media:title type="plain">DNA NGS genome sequencing</media:title>
      </media:content>
    </item>
    <item>
      <title>Rebrain’s brain targeting AI secures MDR CE mark</title>
      <description>
        <![CDATA[<a href="https://www.cortellis.com/intelligence/qsearch/%22rebrain%20sas%22%20?indexBased=true&searchCategory=ALL">Rebrain SAS</a>'s Optimmri platform received European Medical Device Regulation CE mark certification to enable surgeons to identify areas of interest in the brain during deep brain stimulation procedures for Parkinson's disease and essential tremor. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/719947</guid>
      <pubDate>Fri, 16 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719947-rebrains-brain-targeting-ai-secures-mdr-ce-mark</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/Focal-seizure-illustration.webp?t=1747174585" type="image/jpeg" medium="image" fileSize="146135">
        <media:title type="plain">Illustration of brain and brain waves, concept of focal seizure</media:title>
      </media:content>
    </item>
    <item>
      <title>Kakao Healthcare brings CGM app to Japan</title>
      <description>
        <![CDATA[Step aside, Marco Polo: <a href="https://www.bioworld.com/keywords/45862-kakao-healthcare-corp">Kakao Healthcare Corp.</a> plans to bring PASTA to Japan. PASTA is Kakao's AI-based continuous glucose monitoring (CGM) management mobile application, which will be available in Japan through a new subsidiary as the health care company works to expand its global presence. &nbsp;]]>
      </description>
      <guid>http://www.bioworld.com/articles/719946</guid>
      <pubDate>Fri, 16 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719946-kakao-healthcare-brings-cgm-app-to-japan</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Kakao_Pasta-01feb24.webp?t=1706827230" type="image/jpeg" medium="image" fileSize="179361">
        <media:title type="plain">Kakao Pasta app</media:title>
        <media:description type="plain">Kakao Healthcare Corp. PASTA mobile app for glucose monitoring. Credit: Kakao Healthcare</media:description>
      </media:content>
    </item>
    <item>
      <title>Urine-testing device turns toilets into health trackers</title>
      <description>
        <![CDATA[In what represents just the company’s third PCT filing, Houston-based Starling Medical Inc.’s co-founders, Hannah McKenney and William Hendricks, seek to gain further protection for their at-home urine diagnostic patient-monitoring platform that eliminates the traditional use of catching containers and dipsticks.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719944</guid>
      <pubDate>Fri, 16 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719944-urine-testing-device-turns-toilets-into-health-trackers</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/urine-testing-device-16may25.webp?t=1747425021" type="image/jpeg" medium="image" fileSize="115210">
        <media:title type="plain">urine testing device</media:title>
        <media:description type="plain">WO2025090837-A1, “Bodily fluid management system.”Assignee: Starling Medical Inc.Inventors: McKenney, Hannah; Hendricks, William AndrewIPC codes: G01N 33/493; G01N 15/075; G01N 15/14; A61B 5/20; A61B 5/00; A61B 10/00Publication date: May 1, 2025Earliest priority details: US2023593148, Oct. 25, 2023</media:description>
      </media:content>
    </item>
  </channel>
</rss>
